$0.0004
0[0.00%]
Last update: 3:51PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$0.05
0.0496[12400.00%]
| Open- | Close- |
| Vol / Avg.0 / 2.436K | Mkt Cap26.400K |
| Day Range- - - | 52 Wk Range0.000 - 0.050 |
Acura Pharmaceuticals Stock (OTC:ACUR), Key Statistics
Acura Pharmaceuticals Stock (OTC: ACUR) analysis, key statistics.
Valuation Measures
Enterprise Value
161.4K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.01
Price / Book (mrq)
0.15
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-5000%
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
682K
Total Assets
860K
Total Liabilities
682K
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
80.56%
EBIT Margin
80.56%
EBITDA Margin
155.56%
Operating Margin
-658.33%
Acura Pharmaceuticals Stock (OTC:ACUR), Key Statistics
Acura Pharmaceuticals Stock (OTC: ACUR) analysis, key statistics.
Valuation Measures
Enterprise Value
161.4K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.01
Price / Book (mrq)
0.15
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-5000%
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
682K
Total Assets
860K
Total Liabilities
682K
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
80.56%
EBIT Margin
80.56%
EBITDA Margin
155.56%
Operating Margin
-658.33%
Acura Pharmaceuticals Stock (OTC:ACUR), Key Statistics
Acura Pharmaceuticals Stock (OTC: ACUR) analysis, key statistics.
Valuation Measures
Enterprise Value
161.4K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.01
Price / Book (mrq)
0.15
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-5000%
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
682K
Total Assets
860K
Total Liabilities
682K
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
80.56%
EBIT Margin
80.56%
EBITDA Margin
155.56%
Operating Margin
-658.33%
Acura Pharmaceuticals Stock (OTC:ACUR), Key Statistics
Acura Pharmaceuticals Stock (OTC: ACUR) analysis, key statistics.
Valuation Measures
Enterprise Value
161.4K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.01
Price / Book (mrq)
0.15
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-5000%
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
682K
Total Assets
860K
Total Liabilities
682K
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
80.56%
EBIT Margin
80.56%
EBITDA Margin
155.56%
Operating Margin
-658.33%
Acura Pharmaceuticals Stock (OTC:ACUR), Key Statistics
Acura Pharmaceuticals Stock (OTC: ACUR) analysis, key statistics.
Valuation Measures
Enterprise Value
161.4K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.01
Price / Book (mrq)
0.15
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-5000%
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
682K
Total Assets
860K
Total Liabilities
682K
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
80.56%
EBIT Margin
80.56%
EBITDA Margin
155.56%
Operating Margin
-658.33%
Acura Pharmaceuticals Stock (OTC:ACUR), Key Statistics
Acura Pharmaceuticals Stock (OTC: ACUR) analysis, key statistics.
Valuation Measures
Enterprise Value
161.4K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.01
Price / Book (mrq)
0.15
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-5000%
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
682K
Total Assets
860K
Total Liabilities
682K
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
80.56%
EBIT Margin
80.56%
EBITDA Margin
155.56%
Operating Margin
-658.33%
Acura Pharmaceuticals Stock (OTC:ACUR), Key Statistics
Acura Pharmaceuticals Stock (OTC: ACUR) analysis, key statistics.
Valuation Measures
Enterprise Value
161.4K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.01
Price / Book (mrq)
0.15
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-5000%
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
682K
Total Assets
860K
Total Liabilities
682K
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
80.56%
EBIT Margin
80.56%
EBITDA Margin
155.56%
Operating Margin
-658.33%
Acura Pharmaceuticals Stock (OTC:ACUR), Key Statistics
Acura Pharmaceuticals Stock (OTC: ACUR) analysis, key statistics.
Valuation Measures
Enterprise Value
161.4K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.01
Price / Book (mrq)
0.15
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-5000%
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
682K
Total Assets
860K
Total Liabilities
682K
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
80.56%
EBIT Margin
80.56%
EBITDA Margin
155.56%
Operating Margin
-658.33%
Acura Pharmaceuticals Stock (OTC:ACUR), Key Statistics
Acura Pharmaceuticals Stock (OTC: ACUR) analysis, key statistics.
Valuation Measures
Enterprise Value
161.4K
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
0.01
Price / Book (mrq)
0.15
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-5000%
Price change 1 M
1
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
- -
Tangible Book value per share
- -
Total Liabilities (Quarterly)
682K
Total Assets
860K
Total Liabilities
682K
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
80.56%
EBIT Margin
80.56%
EBITDA Margin
155.56%
Operating Margin
-658.33%